Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer/Cellectis ink meganuclease deal

Bayer CropScience and French genomics company Cellectis’ US subsidiary, Cellectis Plant Sciences (Saint Paul, Minnesota), have agreed a research collaboration for the use of Cellectis’ proprietary meganuclease technology to develop commercial products for the agricultural seed markets using new breeding techniques such as gene stacking and targeted mutagenesis. Cellectis will provide Bayer with custom-designed meganucleases for plant genomes, to introduce targeted modifications to selected genes and genomes. The agreement is a broadening of a collaboration deal between the two companies that began in 2006 ( Agrow No 499, p 5). Financial terms have not been disclosed.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG005721

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel